Swedish Orphan Biovitrum AB (publ) (BIOVF)

BIOVF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,013	9,959	9,119	6,204	6,120	5,964
Market Cap Growth	13.51%	9.22%	46.98%	1.37%	2.62%	22.62%
Enterprise Value	13,325	11,522	11,146	7,153	7,393	7,565
Last Close Price	34.88	27.66	26.25	21.15	20.39	19.55
PE Ratio	8707.30	28.37	38.07	24.52	20.66	15.10
PS Ratio	4.06	4.24	4.14	3.44	3.56	3.21
PB Ratio	3.15	2.74	2.71	2.44	2.38	2.42
P/FCF Ratio	15.43	15.27	25.50	14.36	10.21	10.03
P/OCF Ratio	15.34	14.92	20.52	14.13	10.12	9.94
EV/Sales Ratio	4.58	4.90	5.07	3.97	4.31	4.07
EV/EBITDA Ratio	11.91	13.74	14.87	11.31	11.93	9.83
EV/EBIT Ratio	17.87	21.90	24.09	16.50	17.62	13.92
EV/FCF Ratio	17.12	17.67	31.16	16.56	12.33	12.72
Debt / Equity Ratio	0.38	0.42	0.61	0.34	0.47	0.72
Debt / EBITDA Ratio	1.27	1.78	2.67	1.36	1.91	2.27
Debt / FCF Ratio	1.85	2.32	5.70	2.02	2.01	2.98
Asset Turnover	0.40	0.35	0.35	0.37	0.32	0.33
Inventory Turnover	1.41	1.42	1.38	1.31	1.08	1.34
Quick Ratio	0.69	0.68	0.42	0.51	0.59	0.47
Current Ratio	1.02	1.05	0.64	0.76	1.00	0.78
Return on Equity (ROE)	0.01%	10.46%	7.98%	10.61%	12.34%	17.48%
Return on Assets (ROA)	6.41%	4.87%	4.60%	5.58%	4.89%	5.94%
Return on Capital (ROIC)	8.53%	6.54%	6.46%	8.10%	6.88%	8.17%
Return on Capital Employed (ROCE)	13.50%	9.30%	8.50%	12.00%	9.50%	11.80%
Earnings Yield	0.01%	3.52%	2.63%	4.08%	4.84%	6.63%
FCF Yield	6.48%	6.55%	3.92%	6.96%	9.80%	9.97%
Buyback Yield / Dilution	1.02%	-6.01%	-9.22%	-0.56%	0.28%	-1.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.